|1 Table of Contents 3
|1.1 List of Tables 6
|1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Biopsy Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Biopsy Devices Market, North America 12
3.1 Biopsy Devices Market, North America, Revenue ($m), 2018-2033 12
3.2 Biopsy Devices Market, North America, Revenue ($m), 2018-2033 14
3.3 Biopsy Devices Market, North America, Volume (Units), 2018-2033 16
3.4 Biopsy Devices Market, North America, Volume (Units), 2018-2033 18
3.5 Biopsy Devices Market, North America, Company Share by Revenue ($m), 2024 21
4 Biopsy Devices Market, Canada 23
4.1 Biopsy Devices Market, Canada, Revenue ($m), 2018-2033 23
4.1.1 Biopsy Forceps Market, Canada, Revenue ($m), by Segment, 2018-2033 25
4.1.2 Biopsy Guns Market, Canada, Revenue ($m), by Segment, 2018-2033 27
4.1.3 Biopsy Needles Market, Canada, Revenue ($m), by Segment, 2018-2033 29
4.1.4 Biopsy Punches Market, Canada, Revenue ($m), by Segment, 2018-2033 31
4.1.5 Vacuum-Assisted Needle Devices Market, Canada, Revenue ($m), by Segment, 2018-2033 33
4.2 Biopsy Devices Market, Canada, Volume (Units), 2018-2033 35
4.2.1 Biopsy Forceps Market, Canada, Volume (Units), by Segment, 2018-2033 37
4.2.2 Biopsy Guns Market, Canada, Volume (Units), by Segment, 2018-2033 39
4.2.3 Biopsy Needles Market, Canada, Volume (Units), by Segment, 2018-2033 41
4.2.4 Biopsy Punches Market, Canada, Volume (Units), by Segment, 2018-2033 43
4.2.5 Vacuum-Assisted Needle Devices Market, Canada, Volume (Units), by Segment, 2018-2033 45
4.3 Biopsy Devices Market, Canada, Average Price ($) , 2018-2033 47
4.4 Biopsy Devices Market, Canada, Company Share by Revenue ($m), 2024 49
5 Biopsy Devices Market, Mexico 51
5.1 Biopsy Devices Market, Mexico, Revenue ($m), 2018-2033 51
5.1.1 Biopsy Forceps Market, Mexico, Revenue ($m), by Segment, 2018-2033 53
5.1.2 Biopsy Guns Market, Mexico, Revenue ($m), by Segment, 2018-2033 55
5.1.3 Biopsy Needles Market, Mexico, Revenue ($m), by Segment, 2018-2033 57
5.1.4 Biopsy Punches Market, Mexico, Revenue ($m), by Segment, 2018-2033 59
5.1.5 Vacuum-Assisted Needle Devices Market, Mexico, Revenue ($m), by Segment, 2018-2033 61
5.2 Biopsy Devices Market, Mexico, Volume (Units), 2018-2033 63
5.2.1 Biopsy Forceps Market, Mexico, Volume (Units), by Segment, 2018-2033 65
5.2.2 Biopsy Guns Market, Mexico, Volume (Units), by Segment, 2018-2033 67
5.2.3 Biopsy Needles Market, Mexico, Volume (Units), by Segment, 2018-2033 69
5.2.4 Biopsy Punches Market, Mexico, Volume (Units), by Segment, 2018-2033 71
5.2.5 Vacuum-Assisted Needle Devices Market, Mexico, Volume (Units), by Segment, 2018-2033 73
5.3 Biopsy Devices Market, Mexico, Average Price ($) , 2018-2033 75
5.4 Biopsy Devices Market, Mexico, Company Share by Revenue ($m), 2024 77
6 Biopsy Devices Market, United States 79
6.1 Biopsy Devices Market, United States, Revenue ($m), 2018-2033 79
6.1.1 Biopsy Forceps Market, United States, Revenue ($m), by Segment, 2018-2033 81
6.1.2 Biopsy Guns Market, United States, Revenue ($m), by Segment, 2018-2033 83
6.1.3 Biopsy Needles Market, United States, Revenue ($m), by Segment, 2018-2033 85
6.1.4 Biopsy Punches Market, United States, Revenue ($m), by Segment, 2018-2033 87
6.1.5 Vacuum-Assisted Needle Devices Market, United States, Revenue ($m), by Segment, 2018-2033 89
6.2 Biopsy Devices Market, United States, Volume (Units), 2018-2033 91
6.2.1 Biopsy Forceps Market, United States, Volume (Units), by Segment, 2018-2033 94
6.2.2 Biopsy Guns Market, United States, Volume (Units), by Segment, 2018-2033 96
6.2.3 Biopsy Needles Market, United States, Volume (Units), by Segment, 2018-2033 98
6.2.4 Biopsy Punches Market, United States, Volume (Units), by Segment, 2018-2033 101
6.2.5 Vacuum-Assisted Needle Devices Market, United States, Volume (Units), by Segment, 2018-2033 103
6.3 Biopsy Devices Market, United States, Average Price ($) , 2018-2033 105
6.4 Biopsy Devices Market, United States, Company Share by Revenue ($m), 2024 107
7 Overview of Key Companies in North America Biopsy Devices Market 109
7.1 Becton Dickinson and Co 109
7.1.1 Company Overview 109
7.2 Hologic Inc 109
7.2.1 Company Overview 109
7.3 Boston Scientific Corp 109
7.3.1 Company Overview 109
7.4 Argon Medical Devices Inc 109
7.4.1 Company Overview 109
7.5 Merit Medical Systems Inc 110
7.5.1 Company Overview 110
7.6 Olympus Corp 110
7.6.1 Company Overview 110
7.7 Devicor Medical Products Inc 110
7.7.1 Company Overview 110
7.8 Medtronic Plc 110
7.8.1 Company Overview 110
8 Biopsy Devices Market Pipeline Products 111
9 Recent Developments 115
9.1 Corporate Communications 115
9.1.1 Feb 18, 2025: Industry Leaders Join Mizzou Cybersecurity Advisory Board 115
9.1.2 Dec 09, 2024: Hologic Appoints Dr. Martin Madaus to Its Board 115
9.2 Financial Announcements 115
9.2.1 Mar 19, 2025: iCAD Posts Results for Q4 and Fiscal Year Ended December 31, 2024 115
9.2.2 Feb 05, 2025: Hologic Reports Results for Q1 of Fiscal 2025 117
9.2.3 Jan 06, 2025: Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025 118
9.2.4 Dec 19, 2024: Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30 118
9.2.5 Nov 01, 2024: Cardinal Health Announces Q1 Fiscal Year 2025 Results 118
9.2.6 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024 119
9.2.7 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024 120
9.2.8 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024 120
9.2.9 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results 121
9.2.10 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results 121
9.2.11 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance 121
9.2.12 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance 122
9.2.13 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024 123
9.3 Government and Public Interest 124
9.3.1 Jan 14, 2025: NFCR-Supported Scientists Advance Liquid Biopsy Technology 124
9.3.2 Jan 06, 2025: FDA Issues Draft Guidance on Including Tissue Biopsies in Clinical Trials 124
9.3.3 Sep 30, 2024: Study Advocates for Alternative Biopsy Approach to Detecting Prostate Cancer 125
9.3.4 Jul 09, 2024: BioCryst : ORLADEYO (Berotralstat) Approved in Peru 125
9.4 Other Significant Developments 126
9.4.1 Jan 27, 2025: UC Davis Health places order for BiBBInstruments' EndoDrill GI cancer care device 126
9.4.2 Aug 15, 2024: Alpenglow Biosciences And Partners Secure A Total Of $24m For Development Of Alpenglow’s 3d Spatial Pathology Platform 127
9.5 Product News 128
9.5.1 Jun 17, 2025: Clarity Enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx 128
9.5.2 Nov 13, 2024: Fifteen Radiology Partners Physicians Participating in Multiple RSNA 2024 Sessions 129
9.5.3 Nov 11, 2024: Syndeo Medical Announces European MDR Approval for Two Product Brands 131
9.5.4 Sep 19, 2024: Northwestern Medicine Study Advocates for Alternative Biopsy Approach for Detecting Prostate Cancer 132
9.5.5 Sep 13, 2024: Endo Presents Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 132
9.6 Strategy And Business Planning 133
9.6.1 Jun 04, 2025: Wolters Kluwer Launches AI-enhanced UpToDate Enterprise Edition in EMEA 133
9.6.2 Mar 18, 2025: Aiosyn and Pramana partner for real time kidney biopsy assessment 134
10 Appendix 136
10.1 Research Methodology 137
10.1.1 Coverage 137
10.1.2 Secondary Research 137
10.1.3 Primary Research 138
10.1.4 Market Modeling and Forecasting 139
10.1.5 Company Share Analysis 140
10.1.6 Benchmarking 141
10.2 GlobalData Consulting 141
10.3 Contact Us 141
10.4 Disclaimer 142